Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine
DeviceTalks Podcast Network
Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Jul 23 2021 | 00:42:16

/
Episode • July 23, 2021 • 00:42:16

Hosted By

Kayleen Brown Tom Salemi

Show Notes

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Previous Episode

Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion

Next Episode

What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Other Episodes

August 19, 2022

DTW - What’s the state of the Medtech job market? We go to the pros to hear things you need to know

In this episode of the DeviceTalks Weekly Podcast, we collect three very different perspectives on what it takes to find jobs/employees in this current...

Play

01:03:31

September 17, 2021

How ResMed, Inspire Medical Woke Up Demand for Innovative Apnea Devices & Data

Zoll Medical’s acquisition of Itamar Medical is just latest sign of the opportunity diagnosing and treating sleep apnea presents to medical device companies, especially...

Play

01:11:42

June 11, 2013

Inside Soteira with CEO Larry Jasinski

Soteira CEO Larry Jasinski talks to MassDevice about overcoming the odds with spinal fusion devices and managing a 510(k) win even after the FDA...

Play

00:18:13